We would like to reassure all patients that our clinical trials are continuing to operate as normal. If you have any questions, do not hesitate to get in touch. Stay safe

Multiple Myeloma Research Survey

David CoganDavid Cogan

Many different types of drugs are now available to treat multiple myeloma.

While the effectiveness of these treatments is important to managing the disease, it isn’t the only important factor to the patients who take them. Drugs may help treat disease, but they can also have a significant further impact on the way we feel or live our lives. ​

The aim of this research project is to find out what characteristics of the treatment for relapsed/refractory multiple myeloma (RRMM) are most important to you. This will help better inform future treatment in the context of the needs and preferences of those affected.  ​

If you are interested in taking part, please complete our survey. Alternatively, give us a call on 0141 946 7888 to find out more and check your eligibility.

The survey is likely to only take you 10-15 minutes. For your time and participation in this study, you will be paid £15.

Thank you for your interest in this research and taking the opportunity to make your voice heard.​

Make sure you stay up-to-date with the latest news, developments and clinical trial updates on our FacebookTwitterLinkedIn and, of course, on our website

You can also be the first to know about the launch of a new clinical trial by signing up to our Research Register.

Your Health and Wellbeing

Our Safety Procedures

Temperature checks

Everyone is required to have a temperature check as they enter the clinic.

Hand Sanitising

Multiple hand sanitisation stations are located throughout the clinic. Frequent hand cleaning is followed by all of our staff.

PPE (PERSONAL protective equipment)

All staff will be equipped with personal protective equipment to keep you and them as safe as possible.


Every consultation room and visiting area is deep cleaned between visits to ensure your safety.


Social distancing of 2M will be in effect at all times within the clinic.


Each clinical room is fitted with a 0.1 micron HEPA air filtration system which filters the air removing viral particles.